Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype

Semyon Gurgov, Kerlly J. Bernabé, John Stites, Christopher M Cunniff, Karen Lin-Su, Diane Felsen, Maria I. New, Dix P. Poppas

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Mutations of CYP21A2 variably decrease 21-hydroxylase activity and result in a spectrum of disease expressions in patients with congenital adrenal hyperplasia (CAH). We examined the association between CYP21A2 mutations and virilization (Prader score) in females with CAH. The study population included 187 CAH females with fully characterized CYP21A2 mutations. One hundred fifty-eight patients were sorted into groups by expected enzyme activity (percent of normal activity) of the less severely affected allele: (A) null, 0%; (B) I2G, 1%; (C) I172N, 2%; and (D) V281L, >2%. We observed an inverse relationship between virilization and residual enzyme activity (P < 0.001). Subjects in group A or B had a significantly higher likelihood (unadjusted odds ratio: 16; P < 0.001) of developing severe virilization compared with those in group C. Surprisingly, 24% of group D patients, whose mutation is usually associated with nonclassical (NC) CAH, had severe virilization. Among subjects with the NC P30L mutation, 66% expressed unexpected virilization. Virilization, usually leading to extensive reconstructive surgery, is highly likely in patients with null or I2G mutations; however, NC mutations (P30L/V281L) may also lead to unexpected virilization. These findings have implications for prenatal counseling and highlight the need for additional investigations into other factors that influence virilization in CAH.

Original languageEnglish (US)
JournalAnnals of the New York Academy of Sciences
DOIs
StateAccepted/In press - 2017
Externally publishedYes

Fingerprint

Virilism
Congenital Adrenal Hyperplasia
Enzyme activity
Genotype
Steroid 21-Hydroxylase
Mutation
Surgery
Reconstructive Surgical Procedures
Enzymes
Counseling
Alleles
Odds Ratio

Keywords

  • Congenital adrenal hyperplasia
  • Genetic mutation
  • Genital atypia
  • P30L mutation
  • Virilization

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype. / Gurgov, Semyon; Bernabé, Kerlly J.; Stites, John; Cunniff, Christopher M; Lin-Su, Karen; Felsen, Diane; New, Maria I.; Poppas, Dix P.

In: Annals of the New York Academy of Sciences, 2017.

Research output: Contribution to journalArticle

Gurgov, Semyon ; Bernabé, Kerlly J. ; Stites, John ; Cunniff, Christopher M ; Lin-Su, Karen ; Felsen, Diane ; New, Maria I. ; Poppas, Dix P. / Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype. In: Annals of the New York Academy of Sciences. 2017.
@article{b81d14769b884b718a57ededa3976eb6,
title = "Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype",
abstract = "Mutations of CYP21A2 variably decrease 21-hydroxylase activity and result in a spectrum of disease expressions in patients with congenital adrenal hyperplasia (CAH). We examined the association between CYP21A2 mutations and virilization (Prader score) in females with CAH. The study population included 187 CAH females with fully characterized CYP21A2 mutations. One hundred fifty-eight patients were sorted into groups by expected enzyme activity (percent of normal activity) of the less severely affected allele: (A) null, 0{\%}; (B) I2G, 1{\%}; (C) I172N, 2{\%}; and (D) V281L, >2{\%}. We observed an inverse relationship between virilization and residual enzyme activity (P < 0.001). Subjects in group A or B had a significantly higher likelihood (unadjusted odds ratio: 16; P < 0.001) of developing severe virilization compared with those in group C. Surprisingly, 24{\%} of group D patients, whose mutation is usually associated with nonclassical (NC) CAH, had severe virilization. Among subjects with the NC P30L mutation, 66{\%} expressed unexpected virilization. Virilization, usually leading to extensive reconstructive surgery, is highly likely in patients with null or I2G mutations; however, NC mutations (P30L/V281L) may also lead to unexpected virilization. These findings have implications for prenatal counseling and highlight the need for additional investigations into other factors that influence virilization in CAH.",
keywords = "Congenital adrenal hyperplasia, Genetic mutation, Genital atypia, P30L mutation, Virilization",
author = "Semyon Gurgov and Bernab{\'e}, {Kerlly J.} and John Stites and Cunniff, {Christopher M} and Karen Lin-Su and Diane Felsen and New, {Maria I.} and Poppas, {Dix P.}",
year = "2017",
doi = "10.1111/nyas.13370",
language = "English (US)",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype

AU - Gurgov, Semyon

AU - Bernabé, Kerlly J.

AU - Stites, John

AU - Cunniff, Christopher M

AU - Lin-Su, Karen

AU - Felsen, Diane

AU - New, Maria I.

AU - Poppas, Dix P.

PY - 2017

Y1 - 2017

N2 - Mutations of CYP21A2 variably decrease 21-hydroxylase activity and result in a spectrum of disease expressions in patients with congenital adrenal hyperplasia (CAH). We examined the association between CYP21A2 mutations and virilization (Prader score) in females with CAH. The study population included 187 CAH females with fully characterized CYP21A2 mutations. One hundred fifty-eight patients were sorted into groups by expected enzyme activity (percent of normal activity) of the less severely affected allele: (A) null, 0%; (B) I2G, 1%; (C) I172N, 2%; and (D) V281L, >2%. We observed an inverse relationship between virilization and residual enzyme activity (P < 0.001). Subjects in group A or B had a significantly higher likelihood (unadjusted odds ratio: 16; P < 0.001) of developing severe virilization compared with those in group C. Surprisingly, 24% of group D patients, whose mutation is usually associated with nonclassical (NC) CAH, had severe virilization. Among subjects with the NC P30L mutation, 66% expressed unexpected virilization. Virilization, usually leading to extensive reconstructive surgery, is highly likely in patients with null or I2G mutations; however, NC mutations (P30L/V281L) may also lead to unexpected virilization. These findings have implications for prenatal counseling and highlight the need for additional investigations into other factors that influence virilization in CAH.

AB - Mutations of CYP21A2 variably decrease 21-hydroxylase activity and result in a spectrum of disease expressions in patients with congenital adrenal hyperplasia (CAH). We examined the association between CYP21A2 mutations and virilization (Prader score) in females with CAH. The study population included 187 CAH females with fully characterized CYP21A2 mutations. One hundred fifty-eight patients were sorted into groups by expected enzyme activity (percent of normal activity) of the less severely affected allele: (A) null, 0%; (B) I2G, 1%; (C) I172N, 2%; and (D) V281L, >2%. We observed an inverse relationship between virilization and residual enzyme activity (P < 0.001). Subjects in group A or B had a significantly higher likelihood (unadjusted odds ratio: 16; P < 0.001) of developing severe virilization compared with those in group C. Surprisingly, 24% of group D patients, whose mutation is usually associated with nonclassical (NC) CAH, had severe virilization. Among subjects with the NC P30L mutation, 66% expressed unexpected virilization. Virilization, usually leading to extensive reconstructive surgery, is highly likely in patients with null or I2G mutations; however, NC mutations (P30L/V281L) may also lead to unexpected virilization. These findings have implications for prenatal counseling and highlight the need for additional investigations into other factors that influence virilization in CAH.

KW - Congenital adrenal hyperplasia

KW - Genetic mutation

KW - Genital atypia

KW - P30L mutation

KW - Virilization

UR - http://www.scopus.com/inward/record.url?scp=85021282006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021282006&partnerID=8YFLogxK

U2 - 10.1111/nyas.13370

DO - 10.1111/nyas.13370

M3 - Article

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -